ABVC BioPharma Inc (ABVC)
1.06
-0.04
(-3.64%)
USD |
NASDAQ |
May 10, 16:00
1.065
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Free Cash Flow (Quarterly): -0.4795M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.4795M |
| September 30, 2023 | -1.380M |
| June 30, 2023 | -0.8998M |
| March 31, 2023 | -1.498M |
| December 31, 2022 | -0.4612M |
| September 30, 2022 | -0.5181M |
| June 30, 2022 | -3.451M |
| March 31, 2022 | -3.088M |
| December 31, 2021 | -2.525M |
| September 30, 2021 | -2.234M |
| June 30, 2021 | -1.444M |
| March 31, 2021 | -1.413M |
| December 31, 2020 | -2.188M |
| September 30, 2020 | -0.3288M |
| June 30, 2020 | -1.416M |
| March 31, 2020 | -0.6309M |
| December 31, 2019 | -1.496M |
| September 30, 2019 | -0.2422M |
| June 30, 2019 | -0.797M |
| March 31, 2019 | -0.5995M |
| December 31, 2018 | 0.5381M |
| September 30, 2018 | -0.2103M |
| June 30, 2018 | -0.4325M |
| March 31, 2018 | -0.5255M |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.3232M |
| June 30, 2017 | -0.1884M |
| March 31, 2017 | -0.8622M |
| December 31, 2016 | -0.2249M |
| September 30, 2016 | -0.2114M |
| June 30, 2016 | -2.834M |
| March 31, 2016 | 0.4454M |
| December 31, 2015 | -0.8743M |
| September 30, 2015 | 0.0011M |
| June 30, 2015 | 0.0023M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.0012M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | -0.0002M |
| March 31, 2013 | -0.0012M |
| December 31, 2012 | -0.0364M |
| September 30, 2012 | -0.0942M |
| June 30, 2012 | -0.2405M |
| March 31, 2012 | -0.2153M |
| December 31, 2011 | -0.3847M |
| September 30, 2011 | -0.3016M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.451M
Minimum
Jun 2022
-0.2422M
Maximum
Sep 2019
-1.394M
Average
-1.413M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -2.003M |
| Sutro Biopharma Inc | 12.63M |
| Reviva Pharmaceuticals Holdings Inc | -8.876M |
| Flora Growth Corp | -1.164M |
| Journey Medical Corp | -16.52M |